Del Giudice, M.L.; Gozzetti, A.; Antonioli, E.; Orciuolo, E.; Ghio, F.; Ciofini, S.; Candi, V.; Fontanelli, G.; Attucci, I.; Formica, G.;
et al. Real-Life Experience with Pomalidomide plus Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma: A Retrospective and Prospective Study. Medicina 2021, 57, 900.
https://doi.org/10.3390/medicina57090900
AMA Style
Del Giudice ML, Gozzetti A, Antonioli E, Orciuolo E, Ghio F, Ciofini S, Candi V, Fontanelli G, Attucci I, Formica G,
et al. Real-Life Experience with Pomalidomide plus Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma: A Retrospective and Prospective Study. Medicina. 2021; 57(9):900.
https://doi.org/10.3390/medicina57090900
Chicago/Turabian Style
Del Giudice, Maria Livia, Alessandro Gozzetti, Elisabetta Antonioli, Enrico Orciuolo, Francesco Ghio, Sara Ciofini, Veronica Candi, Giulia Fontanelli, Irene Attucci, Giuseppe Formica,
and et al. 2021. "Real-Life Experience with Pomalidomide plus Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma: A Retrospective and Prospective Study" Medicina 57, no. 9: 900.
https://doi.org/10.3390/medicina57090900
APA Style
Del Giudice, M. L., Gozzetti, A., Antonioli, E., Orciuolo, E., Ghio, F., Ciofini, S., Candi, V., Fontanelli, G., Attucci, I., Formica, G., Bocchia, M., Galimberti, S., Petrini, M., & Buda, G.
(2021). Real-Life Experience with Pomalidomide plus Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma: A Retrospective and Prospective Study. Medicina, 57(9), 900.
https://doi.org/10.3390/medicina57090900